Jensen B N, Nielsen T L, Lerche B, Jensen T H, Backer V, Mathiesen L, Nielsen J O, Skinhøj P
Department of Infectious Diseases, State University Hospital, Copenhagen, Denmark.
Scand J Infect Dis. 1990;22(5):533-6. doi: 10.3109/00365549009027092.
The effectiveness of biweekly administration of 60 mg aerosolised pentamidine (AP) as secondary prophylaxis against relapse of Pneumocystis carinii pneumonia (PCP) was investigated in 45 male AIDS patients. The nebuliser used was an Acorn System 22. In total the patients received AP for a mean period of 13.8 months (3.4-28.8). Six episodes of recurrent PCP were recorded. Relapse per full year of treatment on AP was 12%.
在45名男性艾滋病患者中,研究了每两周雾化吸入60毫克喷他脒(AP)作为预防卡氏肺孢子虫肺炎(PCP)复发的二级预防措施的有效性。使用的雾化器是Acorn System 22。患者总共接受AP治疗的平均时间为13.8个月(3.4 - 28.8个月)。记录到6例PCP复发事件。接受AP治疗的每完整一年的复发率为12%。